Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders

BACKGROUND: Although previous studies described the production of IgG antibodies in a subgroup of patients with common variable immunodeficiency (CVID) following messenger RNA vaccinations with BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (CVID responders), the functionality...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauerwein, Kai M.T., Geier, Christoph B., Stemberger, Roman F., Rossmanith, Raphael, Akyaman, Hüseyin, Illes, Peter, Fischer, Michael B., Eibl, Martha M., Walter, Jolan E., Wolf, Hermann M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2023
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715258/
https://www.ncbi.nlm.nih.gov/pubmed/36463978
http://dx.doi.org/10.1016/j.jaci.2022.11.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715258/
https://www.ncbi.nlm.nih.gov/pubmed/36463978
http://dx.doi.org/10.1016/j.jaci.2022.11.013

Ejemplares similares